Tech Company Financing Transactions
Mid-Atlantic Biotherapeutics Funding Round
Legend Innovation Life Science Fund participated in a $50 million funding round for Mid-Atlantic Biotherapeutics. This venture round was announced on 8/28/2025.
Transaction Overview
Company Name
Announced On
8/28/2025
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support its continued clinical development, research initiatives, and regulatory efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3805 Old Easton Road
Doylestown, PA 18902
USA
Doylestown, PA 18902
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
MABT was founded in 2011 with the simple goal of making a meaningful difference on the lives of patients, families and communities worldwide. We are especially excited about our work on neurodegenerative conditions such as Alzheimer's, Parkinson's and ALS. Mid-Atlantic BioTherapeutics is committed to pushing the boundaries of scientific understanding and therapeutic efficacy to address an unmet need for diseases that are hard to treat. By leveraging the power of biotechnology and artificial intelligence, we believe that we may be able to treat currently incurable diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Horn
Browse more venture capital transactions:
Prev: 8/28/2025: ALIGNMT AI venture capital transaction
Next: 8/28/2025: Wugen venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs